Mucormycosis Treatments

Find Mucormycosis Treatments

Brand Name

Cresemba

Generic Name
Isavuconazonium
View Brand Information
FDA approval date: March 06, 2015
Classification: Azole Antifungal
Form: Injection, Capsule

What is Cresemba (Isavuconazonium)?

CRESEMBA ® is an azole antifungal indicated for the treatment of: Invasive aspergillosis.

Approved To Treat

Top Global Experts

View All
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

There is no clinical trials being done for this treatment

Related Latest Advances

Voriconazole-Induced Pancreatitis Despite Therapeutic Trough Concentrations During Treatment of Disseminated Fusariosis in a Hospitalized Patient.
Voriconazole-Induced Pancreatitis Despite Therapeutic Trough Concentrations During Treatment of Disseminated Fusariosis in a Hospitalized Patient.
Journal: The American journal of case reports
Published: August 23, 2026
Navigating Therapeutic drug monitoring of Isavuconazole in Invasive Mold Infection on Extracorporeal membrane oxygenation - A Case Report.
Navigating Therapeutic drug monitoring of Isavuconazole in Invasive Mold Infection on Extracorporeal membrane oxygenation - A Case Report.
Journal: Innovations in pharmacy
Published: June 08, 2026
Severe fever with thrombocytopenia syndrome complicated by invasive pulmonary aspergillosis and septic shock: a case report highlighting the role of mNGS.
Severe fever with thrombocytopenia syndrome complicated by invasive pulmonary aspergillosis and septic shock: a case report highlighting the role of mNGS.
Journal: Frontiers in medicine
Published: May 22, 2026
View All Latest Advances